EX-99.1 2 tm2213504d1_ex99-1.htm JOINT FILING AGREEMENT

 

 

EXHIBIT 99.1

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the common stock of IO Biotech, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigned.

 

This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.

 

Dated this 25th day of April, 2022.

 

PFM HEALTH SCIENCES, LP   PFM HEALTH SCIENCES GP, LLC
     
By: PFM Health Sciences GP, LLC,   By: /s/ Darin Sadow
  its general partner     Darin Sadow, Authorized Signatory
     
By: /s/ Darin Sadow    
  Darin Sadow, Authorized Signatory    

 

PFM ASSET MANAGEMENT, LLC   BRIAN D. GROSSMAN
     
By:

PFM Health Sciences GP, LLC,

   By: /s/ Darin Sadow
  its manager     Darin Sadow, attorney-in-fact
     
By: /s/ Darin Sadow  
  Darin Sadow, Authorized Signatory